CD4 and breast cancer: According to Liu et al. a copper-depleting compound named tetrathiomolybdate can reduce the deposition of collagen, lower the accumulation of MDSCs, and boost the CD4+ T-cell infiltration, which alters collagen remodeling in the PMN and inhibits BC metastasis 128.